Evaxion Biotech News

Evaxion Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Merck & Co., Inc.(12.9%),Merck Sharp & Dohme LLC(12.9%), etc.

Nov 6 16:13 ET

Evaxion Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 31 10:25 ET

Evaxion Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 28 09:13 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 9 11:01 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 4 07:05 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 3 07:02 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 1 16:37 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 26 08:02 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 20 16:34 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 19 08:34 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 16 07:31 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 9 08:25 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 9 08:25 ET

Evaxion Biotech | 424B4: Prospectus

Aug 23 08:31 ET

Evaxion Biotech | EFFECT: Others

Aug 23 06:07 ET

Evaxion Biotech | CORRESP: CORRESP

Aug 20 13:08 ET

Evaxion Biotech | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Aug 20 08:48 ET

Evaxion Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 19 17:33 ET

Evaxion Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 14 07:19 ET

Evaxion Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 14 07:06 ET